Levetiracetam Injection
Product Images NDC 70069-847

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 70069-847). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Somerset Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Levetiracetam-1000mg-100ml-10mg-ml-alu-pouch-label (Levetiracetam 1000mg 100ml 10mg mL Alu Pouch Label)

This text provides information about a medication called Levetiracetam in 0.75% Sodium Chloride Injection. It contains detailed instructions for usage, storage, and precautions. The medication is meant for intravenous infusion only and each 100 mL contains 1000 mg of Levetiracetam. The dosage information can be found in the package insert. The container is a single-dose dual port bag with an aluminum overwrap and the closure does not contain natural rubber latex. It is advised to check for leaks before use and store the medication within the recommended temperature range.*

FDA Label Image

Levetiracetam-1000mg-100ml-10mg-ml-bag-label (Levetiracetam 1000mg 100ml 10mg mL Bag Label)

This is a description of a pharmaceutical product - Levetiracetam in 0.75% Sodium Chloride Injection. It is a solution for intravenous infusion, with each 100 mL containing 1000 mg of Levetiracetam. The infusion should be done over a period of 15 minutes from a single-dose dual port bag. The product should not be further diluted before use and caution is advised against using plastic containers in series connections. The recommended storage temperature is between 20°C to 25°C. The product is manufactured for Somerset Therapeutics, LLC in Somerset, NJ, and is made in India.*

FDA Label Image

Levetiracetam-1500mg-100ml-15mg-ml-alu-pouch-label (Levetiracetam 1500mg 100ml 15mg mL Alu Pouch Label)

This is a description of Levetiracetam in 0.54% Sodium Chloride Injection, a medication for intravenous infusion. Each 100 mL contains 1500 mg of Levetiracetam (15 mg/mL). The medication is to be infused over a period of 15 minutes and should not be further diluted before use. The package should be checked for leaks before use, to ensure sterility. It is recommended to store the medication at 20° to 25°C (68° to 77°F). The medication comes in a single-dose dual port bag with an aluminum overwrap and the container closure does not contain natural rubber latex.*

FDA Label Image

Levetiracetam-1500mg-100ml-15mg-ml-bag-label (Levetiracetam 1500mg 100ml 15mg mL Bag Label)

This is a description of a medication containing Levetiracetam in 0.54% Sodium Chloride Injection, with a concentration of 1500 mg/100 mL (15 mg/mL). It is intended for intravenous infusion only and should be administered over a period of 15 minutes from a single-dose dual port bag. The solution also contains water for injection, sodium chloride, glacial acetic acid, and sodium acetate trihydrate. The recommended storage conditions are between 20°C to 25°C (68°F to 77°F), with excursions permitted to 15°C to 30°C (59°F to 86°F). It is important not to dilute the solution further before use and to discard any unused portion.*

FDA Label Image

Levetiracetam-500mg-100ml-5mg-ml-alu-pouch-label (Levetiracetam 500mg 100ml 5mg mL Alu Pouch Label)

This is a product description for Levetiracetam, a medication that is administered through intravenous infusion. The medication comes in a 500 mg/100 mL concentration and should be infused over a period of 15 minutes. The instructions include tearing at a specified notch to open the packaging and checking for leaks before use. The product should be stored at specific temperatures. The container closure does not contain natural rubber latex. The manufacturer is Somerset Therapeutics LLC, based in Somerset, NJ. Additional details such as dosage information are available in the package insert.*

FDA Label Image

Levetiracetam-500mg-100ml-5mg-ml-bag-label (Levetiracetam 500mg 100ml 5mg mL Bag Label)

This text provides information about a pharmaceutical product, Levetiracetam in 0.82% Sodium Chloride Injection, with a concentration of 500 mg/100 mL for intravenous infusion. It includes details on the dosage, storage recommendations, caution against using plastic containers in series connections, and instructions for use. The product is a single-dose dual port bag manufactured for Somerset Therapeutics, LLC, with a specific batch code and manufacturing details.*

FDA Label Image

Levetiracetam-caplin-logo (Levetiracetam Caplin Logo)

FDA Label Image

Figure-1 (Levetiracetam Figure 1)

FDA Label Image

Figure-2 (Levetiracetam Figure 2)

This text shows various percentages and mentions a placebo group and two different dosages of Levetiracetam being compared to the placebo. The comparison is stated to be statistically significant.*

FDA Label Image

Figure-3 (Levetiracetam Figure 3)

This is a comparison of two groups: a placebo group with 104 participants and a Levetiracetam group with 180 participants taking 3000 mg/day. The study found that the Levetiracetam group had a statistically significant difference compared to the placebo group.*

FDA Label Image

Figure-4 (Levetiracetam Figure 4)

This text appears to show a comparison between Lovetiracetam and Placebo in a study involving patients. The text includes percentages of patients in different groups as well as mentions of statistical significance between Lovetiracetam and Placebo. The number of patients in each group is also provided (84 for Placebo and 79 for Lovetiracetam).*

FDA Label Image

Str (Levetiracetam Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.